Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Sarcoma and Rare Cancers Congress 2023

How should we treat new molecular entities?

CIC rearranged sarcoma

Date

21 Mar 2023

Session

How should we treat new molecular entities?

Topics

Translational Research;  Radiation Oncology;  Rare Cancers

Tumour Site

Bone Sarcomas;  Soft Tissue Sarcomas

Presenters

Emanuela Palmerini

Authors

E. Wardelmann1, E. Palmerini2

Author affiliations

  • 1 Gerhard-domagk-institute Of Pathology, University Hospital Muenster-Gerhard Domagk Institute of Pathology, 48149 - Muenster/DE
  • 2 Dimes - Experimental, Diagnostic And Specialty Medicine Dept, Istituto Ortopedico Rizzoli, 40136 - Bologna/IT

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Introduction

Presenter: Emanuela Palmerini

Session: How should we treat new molecular entities?

Resources:

Webcast

Q&A and discussion

Presenter: Emanuela Palmerini

Session: How should we treat new molecular entities?

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.